Name | methyl brevifolincarboxylate |
---|---|
Synonyms |
methyl 7,8,9-trihydroxy-3,5-dioxo-1,2,3,5-tetrahydrocyclopenta[c]isochromene-1-carboxylate
Methyl brevifolincarboxylate methyl 7,8,9-trihydroxy-3,5-dioxo-1,2-dihydrocyclopenta[c]isochromene-1-carboxylate |
Description | Methyl brevifolincarboxylate (Brevifolincarboxylic acid methyl ester) is a potent influenza virus PB2 cap-binding inhibitor. Methyl brevifolincarboxylate exhibits inhibitory activity against influenza virus A/Puerto Rico/8/34 (H1N1) and A/Aichi/2/68 (H3N2) with IC50s of 27.16 μM and 33.41 μM. Anti-oxidant activity[1][2]. |
---|---|
Related Catalog | |
In Vitro | Methyl brevifolincarboxylate exhibits significant DPPH radical scavenging activity with an IC50 value of 8.9 μM. |
References |
Density | 1.78g/cm3 |
---|---|
Boiling Point | 633.9ºC at 760mmHg |
Molecular Formula | C14H10O8 |
Molecular Weight | 306.22400 |
Flash Point | 245.9ºC |
Exact Mass | 306.03800 |
PSA | 134.27000 |
LogP | 0.75280 |
Vapour Pressure | 1.15E-16mmHg at 25°C |
Index of Refraction | 1.717 |